Amneal Pharmaceuticals Inc. Dividend Analysis

No. Amneal Pharmaceuticals (AMRX) does not currently pay a dividend. The last payment in our data was in 2018, and nothing has been paid since.

It largely does not. Amneal Pharmaceuticals pays no dividend and we do not see a meaningful reduction in share count over the last twelve months, so cash is being retained in the business or spent on growth rather than returned. That is common for companies reinvesting heavily, and it means your return depends entirely on the share price.

On the numbers, yes. Amneal Pharmaceuticals generated $128 million of free cash flow, which is about $0.39 per share. If it paid out half of that, the dividend would be roughly $0.19 per share, a yield of about 1.0% at the current price. That is an illustration of capacity, not a prediction: the company has given no indication it intends to pay one.

Our Healthcare sector page ranks the companies we cover by dividend score, which combines payout safety, free cash flow coverage and growth record. If income is what you are after, start there rather than with Amneal Pharmaceuticals.